Tomomi Masuda

1.1k total citations
43 papers, 838 citations indexed

About

Tomomi Masuda is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Tomomi Masuda has authored 43 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Ophthalmology and 13 papers in Oncology. Recurrent topics in Tomomi Masuda's work include Retinal Diseases and Treatments (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (7 papers). Tomomi Masuda is often cited by papers focused on Retinal Diseases and Treatments (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (7 papers). Tomomi Masuda collaborates with scholars based in Japan, United States and Greece. Tomomi Masuda's co-authors include Hideaki Hara, Masamitsu Shimazawa, Yoshimi Takai, A. Maeda, Kazuo Aisaka, Shinsuke Nakamura, Yoshiharu Matsuura, Kozo Kaibuchi, Takahito Itoh and Takashi Kitayama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Tomomi Masuda

41 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomomi Masuda Japan 17 453 189 111 83 80 43 838
Silvia M. Sanz‐González Spain 13 504 1.1× 178 0.9× 115 1.0× 73 0.9× 24 0.3× 36 891
Rit Vatsyayan United States 22 634 1.4× 48 0.3× 178 1.6× 68 0.8× 37 0.5× 33 1.1k
Bogdan G. Gugiu United States 14 886 2.0× 152 0.8× 58 0.5× 61 0.7× 15 0.2× 18 1.4k
Ayşegül Çört Türkiye 15 291 0.6× 109 0.6× 75 0.7× 18 0.2× 20 0.3× 25 658
Beiying Qiu Singapore 17 549 1.2× 45 0.2× 74 0.7× 43 0.5× 45 0.6× 32 883
Hisanori Miki Japan 12 463 1.0× 90 0.5× 148 1.3× 48 0.6× 14 0.2× 41 793
Fen-Fen Lin United States 14 644 1.4× 60 0.3× 202 1.8× 71 0.9× 19 0.2× 17 1.0k
Raquel Castellon United States 11 401 0.9× 136 0.7× 60 0.5× 34 0.4× 15 0.2× 18 874
Kenji Katsuno Japan 12 372 0.8× 84 0.4× 95 0.9× 34 0.4× 15 0.2× 15 1.0k
Wei‐En Yang Taiwan 16 713 1.6× 42 0.2× 268 2.4× 51 0.6× 47 0.6× 32 1.3k

Countries citing papers authored by Tomomi Masuda

Since Specialization
Citations

This map shows the geographic impact of Tomomi Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Masuda more than expected).

Fields of papers citing papers by Tomomi Masuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Masuda. The network helps show where Tomomi Masuda may publish in the future.

Co-authorship network of co-authors of Tomomi Masuda

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Masuda. A scholar is included among the top collaborators of Tomomi Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Masuda. Tomomi Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sunaga, Noriaki, et al.. (2024). Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance. Cancers. 16(4). 710–710. 2 indexed citations
2.
Kobayashi, Nao, Noriaki Sunaga, Masakiyo Yatomi, et al.. (2024). A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy. Thoracic Cancer. 16(2). e15512–e15512. 2 indexed citations
3.
Sato, Mari, Masakiyo Yatomi, Tomomi Masuda, et al.. (2023). Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation. Respiratory Medicine Case Reports. 43. 101818–101818. 1 indexed citations
4.
Yatomi, Masakiyo, Haruka Aoki‐Saito, Tomomi Masuda, et al.. (2022). A pregnant woman with severe dyspnoea. Breathe. 18(2). 220012–220012.
5.
Sasaki, Takahiro, Masamitsu Shimazawa, Hiromitsu Kanamori, et al.. (2020). Effects of progranulin on the pathological conditions in experimental myocardial infarction model. Scientific Reports. 10(1). 11842–11842. 12 indexed citations
6.
Imai, Hisao, Kyoichi Kaira, Ichiro Naruse, et al.. (2020). Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC. Anticancer Research. 40(3). 1571–1578. 1 indexed citations
7.
Kasahara, Norimitsu, Noriaki Sunaga, Ichiro Naruse, et al.. (2020). Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study. Supportive Care in Cancer. 28(10). 4825–4831. 9 indexed citations
8.
Imai, Hisao, Kyoichi Kaira, Tomomi Masuda, et al.. (2017). Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 79(3). 497–505. 17 indexed citations
9.
Masuda, Tomomi, Masamitsu Shimazawa, & Hideaki Hara. (2017). Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone). Oxidative Medicine and Cellular Longevity. 2017(1). 9208489–9208489. 177 indexed citations
10.
Masuda, Tomomi, et al.. (2016). Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets. Experimental Eye Research. 146. 196–205. 18 indexed citations
11.
Imai, Hisao, Tomomi Masuda, Kyoichi Kaira, et al.. (2015). First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations. Cancer Chemotherapy and Pharmacology. 76(4). 761–769. 17 indexed citations
12.
Shimazawa, Masamitsu, et al.. (2015). An Experimental Model for Exudative Age-related Macular Degeneration with Choroidal Neovascularization Using the Common Marmoset. Current Neurovascular Research. 12(2). 128–134. 5 indexed citations
13.
Kaira, Kyoichi, Noriaki Sunaga, Hisao Imai, et al.. (2015). Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer. International Journal of Clinical Oncology. 21(2). 240–247. 3 indexed citations
14.
Masuda, Tomomi, Hisao Imai, Yoshiko Miura, et al.. (2015). Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations. Clinical & Translational Oncology. 17(9). 702–709. 12 indexed citations
15.
Masuda, Tomomi, Shinsuke Nakamura, Takahiro Kuchimaru, et al.. (2015). The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe. Scientific Reports. 5(1). 9898–9898. 21 indexed citations
16.
Masuda, Tomomi, et al.. (2014). Tissue kallikrein (kallidinogenase) protects against retinal ischemic damage in mice. European Journal of Pharmacology. 738. 74–82. 11 indexed citations
17.
Masuda, Tomomi, Masamitsu Shimazawa, & Hideaki Hara. (2014). The kallikrein system in retinal damage/protection. European Journal of Pharmacology. 749. 161–163. 8 indexed citations
18.
Kitayama, Takashi, Tomomi Masuda, Yasushi Kawai, et al.. (2001). The chemistry of zerumbone. Part 3: Stereospecific creation of five stereogenic centers by double Sharpless oxidation. Tetrahedron Asymmetry. 12(20). 2805–2810. 23 indexed citations
19.
Aisaka, Kazuo & Tomomi Masuda. (1995). Production of trehalose phosphorylase by Catellatospora ferruginea. FEMS Microbiology Letters. 131(1). 47–51. 16 indexed citations
20.
Itoh, Takahito, Kozo Kaibuchi, Tomomi Masuda, et al.. (1993). The post-translational processing of ras p21 is critical for its stimulation of mitogen-activated protein kinase.. Journal of Biological Chemistry. 268(5). 3025–3028. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia M. Sanz‐González Breakdown of academic impact, for papers by Rit Vatsyayan Breakdown of academic impact, for papers by Bogdan G. Gugiu Breakdown of academic impact, for papers by Ayşegül Çört Breakdown of academic impact, for papers by Beiying Qiu Breakdown of academic impact, for papers by Hisanori Miki Breakdown of academic impact, for papers by Fen-Fen Lin Breakdown of academic impact, for papers by Raquel Castellon Breakdown of academic impact, for papers by Kenji Katsuno Breakdown of academic impact, for papers by Wei‐En Yang
Rankless by CCL
2026